ChemicalBook > CAS DataBase List > DCC-3014

DCC-3014

Product Name
DCC-3014
CAS No.
1628606-05-2
Chemical Name
DCC-3014
Synonyms
DCC-3014;Vimseltinib;DCC-3014(Vimseltinib);Vimseltinib (DCC-3014);2-(Isopropylamino)-3-methyl-5-(6-methyl-5-((2-(1-methyl-1H-pyrazol-4-yl)pyridin-4-yl)oxy)pyridin-2-yl)pyrimidin-4(3H)-one;4(3H)-Pyrimidinone, 3-methyl-2-[(1-methylethyl)amino]-5-[6-methyl-5-[[2-(1-methyl-1H-pyrazol-4-yl)-4-pyridinyl]oxy]-2-pyridinyl]-;CSF1R,CD117,CSF-1 receptor,DCC 3014,SCFR,inhibit,c-Fms,DCC3014,c-Kit,CSF-1R,Vimseltinib,colony stimulating factor 1 receptor,Inhibitor
CBNumber
CB17244101
Molecular Formula
C23H25N7O2
Formula Weight
431.49
MOL File
1628606-05-2.mol
More
Less

DCC-3014 Property

Boiling point:
609.2±65.0 °C(Predicted)
Density 
1.29±0.1 g/cm3(Predicted)
pka
3.20±0.27(Predicted)
form 
Solid
color 
Off-white to light yellow
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H315Causes skin irritation

H319Causes serious eye irritation

Precautionary statements

P264Wash hands thoroughly after handling.

P264Wash skin thouroughly after handling.

P280Wear protective gloves/protective clothing/eye protection/face protection.

P302+P352IF ON SKIN: wash with plenty of soap and water.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

P332+P313IF SKIN irritation occurs: Get medical advice/attention.

P337+P313IF eye irritation persists: Get medical advice/attention.

More
Less

N-Bromosuccinimide Price

ChemScene
Product number
CS-0121044
Product name
DCC-3014
Purity
99.08%
Packaging
5mg
Price
$380
Updated
2021/12/16
ChemScene
Product number
CS-0121044
Product name
DCC-3014
Purity
99.08%
Packaging
10mg
Price
$650
Updated
2021/12/16
ChemScene
Product number
CS-0121044
Product name
DCC-3014
Purity
99.08%
Packaging
25mg
Price
$1250
Updated
2021/12/16
ChemScene
Product number
CS-0121044
Product name
DCC-3014
Purity
99.08%
Packaging
50mg
Price
$2000
Updated
2021/12/16
ChemScene
Product number
CS-0121044
Product name
DCC-3014
Purity
99.08%
Packaging
100mg
Price
$2950
Updated
2021/12/16

DCC-3014 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

DCC-3014 Suppliers

Shanghai XingMo Biotechnology Co., Ltd.
Tel
+86 13524779951; 13524779951
Fax
QQ: 2075692521
Email
2075692521@qq.com
Country
China
ProdList
309
Advantage
55
Taizhou Zhongzhi Biotechnology Co., Ltd
Tel
13012344321
Email
3995296515@qq.com
Country
China
ProdList
7996
Advantage
58
Nanjing Chemlin Chemical Co., Ltd
Tel
025-83697070
Fax
+86-25-83453306
Email
info@chemlin.com.cn
Country
China
ProdList
19179
Advantage
64
ShangHai Caerulum Pharma Discovery Co., Ltd.
Tel
18149758185 18149758185
Email
sales-cpd@caerulumpharma.com
Country
China
ProdList
3466
Advantage
58
Shanghai Lollane Biological Technology Co.,Ltd.
Tel
021-52996696,15000506266 15000506266
Fax
+86-21-52996696
Country
China
ProdList
4566
Advantage
55
Shanghai EFE Biological Technology Co., Ltd.
Tel
021-65675885 18964387627
Fax
021-65675885
Email
info@efebio.com
Country
China
ProdList
9806
Advantage
58
ShangHai Biochempartner Co.,Ltd
Tel
177-54423994 17754423994
Fax
QQ:2853530913
Email
2853530910@QQ.com
Country
China
ProdList
8012
Advantage
62
Beijing Solarbio Science & Tecnology Co., Ltd.
Tel
010-50973130 4009686088
Email
3193328036@qq.com
Country
China
ProdList
29785
Advantage
68
Guangzhou Belka Biological Technology Co., Ltd.
Tel
+86-18665676617
Fax
18665676617
Country
China
ProdList
957
Advantage
58
Jinan Carbotang Biotech Co.,Ltd.
Tel
+8615866703830
Email
figo.gao@foxmail.com
Country
China
ProdList
8497
Advantage
58
DC Chemicals
Tel
021-58447131 13564518121
Email
sales@dcchemicals.com
Country
China
ProdList
9409
Advantage
58
Chunchuang (Wuhan) Technology Co., Ltd
Tel
15342225168
Email
yutianchun2007@126.com
Country
China
ProdList
10003
Advantage
58
Hebei Weite Medical Technology Co., Ltd
Tel
13180081292
Email
contact@wetogethermed.com
Country
China
ProdList
7488
Advantage
58
Hubei Kele Fine Chemical Co., Ltd
Tel
027-59101668 19945030958
Fax
027-59101668
Email
2881924765@qq.com
Country
China
ProdList
7890
Advantage
58
Bide Pharmatech Ltd.
Tel
400-1647117 13681763483
Email
product02@bidepharm.com
Country
China
ProdList
62075
Advantage
58
TargetMol Chemicals Inc.
Tel
4008200310
Email
marketing@tsbiochem.com
Country
China
ProdList
24644
Advantage
58
Suzhou Haiben Pharmaceutical Co., Ltd
Tel
14760821013 13564957716
Email
1816280386@qq.com
Country
China
ProdList
7889
Advantage
58
https://hanhongsci.com/
Tel
021-54306202 18917919676
Email
info@hanhongsci.com
Country
China
ProdList
29979
Advantage
58
Shanghai?Medlife?Pharm-Tech?Co.,?Ltd
Tel
021-59167510 18117107507
Email
vip@med-life.cn
Country
China
ProdList
4997
Advantage
58
Suzhou Meidi Senuo Pharmaceutical Technology Co., Ltd.
Tel
13771642864
Fax
1078336263
Email
snhuyu_2008@126.com
Country
China
ProdList
1112
Advantage
58
Nanjing Shizhou Biology Technology Co.,Ltd
Tel
025-85560043 15850508050
Fax
025-85563444
Email
cindy.huang@synzest.com
Country
China
ProdList
12005
Advantage
58
RD International Technology Co., Limited
Tel
18024082417
Email
market@ubiochem.com
Country
China
ProdList
9266
Advantage
58
Jiangsu Aikon Biopharmaceutical R&D Co.,Ltd
Tel
13915962545
Email
2881759498@qq.com
Country
China
ProdList
3660
Advantage
58
LEAPCHEM CO., LTD.
Tel
+86-852-30606658
Email
market18@leapchem.com
Country
China
ProdList
43340
Advantage
58
Wuhan Topule Biopharmaceutical Co., Ltd
Tel
+8618327326525
Email
masar@topule.com
Country
China
ProdList
8467
Advantage
58
Guangzhou Biocar Biotechnology Co.,Ltd.
Tel
+86-13397196830
Fax
027-86589876
Email
carrie@gzbiocar.cn
Country
China
ProdList
435
Advantage
58

1628606-05-2, DCC-3014Related Search:


  • DCC-3014
  • Vimseltinib
  • CSF1R,CD117,CSF-1 receptor,DCC 3014,SCFR,inhibit,c-Fms,DCC3014,c-Kit,CSF-1R,Vimseltinib,colony stimulating factor 1 receptor,Inhibitor
  • 4(3H)-Pyrimidinone, 3-methyl-2-[(1-methylethyl)amino]-5-[6-methyl-5-[[2-(1-methyl-1H-pyrazol-4-yl)-4-pyridinyl]oxy]-2-pyridinyl]-
  • 2-(Isopropylamino)-3-methyl-5-(6-methyl-5-((2-(1-methyl-1H-pyrazol-4-yl)pyridin-4-yl)oxy)pyridin-2-yl)pyrimidin-4(3H)-one
  • DCC-3014(Vimseltinib)
  • Vimseltinib (DCC-3014)
  • 1628606-05-2